オキシステロール受容体LXRベータのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Oxysterols Receptor LXR Beta Market Insights and Forecast to 2028

• レポートコード：QY2203B02096 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、75ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のオキシステロール受容体LXRベータの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にオキシステロール受容体LXRベータの世界市場のxxx％を占める「AF-122」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「クリニック」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のオキシステロール受容体LXRベータの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのオキシステロール受容体LXRベータ市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのオキシステロール受容体LXRベータ市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 オキシステロール受容体LXRベータのグローバル主要メーカーには、Affichem SA、Bristol-Myers Squibb Company、Kowa Company Ltd、Vitae Pharmaceuticals Incなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 オキシステロール受容体LXRベータ市場は、種類と用途によって区分されます。世界のオキシステロール受容体LXRベータ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 AF-122、BMS-779788、SR-9238、VTP-38543、VTP-4、その他 【用途別セグメント】 クリニック、病院、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - オキシステロール受容体LXRベータ製品概要 - 種類別市場（AF-122、BMS-779788、SR-9238、VTP-38543、VTP-4、その他） - 用途別市場（クリニック、病院、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のオキシステロール受容体LXRベータ販売量予測2017-2028 - 世界のオキシステロール受容体LXRベータ売上予測2017-2028 - オキシステロール受容体LXRベータの地域別販売量 - オキシステロール受容体LXRベータの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別オキシステロール受容体LXRベータ販売量 - 主要メーカー別オキシステロール受容体LXRベータ売上 - 主要メーカー別オキシステロール受容体LXRベータ価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（AF-122、BMS-779788、SR-9238、VTP-38543、VTP-4、その他） - オキシステロール受容体LXRベータの種類別販売量 - オキシステロール受容体LXRベータの種類別売上 - オキシステロール受容体LXRベータの種類別価格 ・用途別市場規模（クリニック、病院、その他） - オキシステロール受容体LXRベータの用途別販売量 - オキシステロール受容体LXRベータの用途別売上 - オキシステロール受容体LXRベータの用途別価格 ・北米市場 - 北米のオキシステロール受容体LXRベータ市場規模（種類別、用途別） - 主要国別のオキシステロール受容体LXRベータ市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのオキシステロール受容体LXRベータ市場規模（種類別、用途別） - 主要国別のオキシステロール受容体LXRベータ市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のオキシステロール受容体LXRベータ市場規模（種類別、用途別） - 主要国別のオキシステロール受容体LXRベータ市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のオキシステロール受容体LXRベータ市場規模（種類別、用途別） - 主要国別のオキシステロール受容体LXRベータ市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのオキシステロール受容体LXRベータ市場規模（種類別、用途別） - 主要国別のオキシステロール受容体LXRベータ市場規模（トルコ、サウジアラビア） ・企業情報 Affichem SA、Bristol-Myers Squibb Company、Kowa Company Ltd、Vitae Pharmaceuticals Inc ・産業チェーン及び販売チャネル分析 - オキシステロール受容体LXRベータの産業チェーン分析 - オキシステロール受容体LXRベータの原材料 - オキシステロール受容体LXRベータの生産プロセス - オキシステロール受容体LXRベータの販売及びマーケティング - オキシステロール受容体LXRベータの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - オキシステロール受容体LXRベータの産業動向 - オキシステロール受容体LXRベータのマーケットドライバー - オキシステロール受容体LXRベータの課題 - オキシステロール受容体LXRベータの阻害要因 ・主な調査結果

Market Analysis and Insights: Global Oxysterols Receptor LXR Beta Market
Due to the COVID-19 pandemic, the global Oxysterols Receptor LXR Beta market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, AF-122 accounting for % of the Oxysterols Receptor LXR Beta global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Clinic segment is altered to an % CAGR throughout this forecast period.
China Oxysterols Receptor LXR Beta market size is valued at US$ million in 2021, while the US and Europe Oxysterols Receptor LXR Beta are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Oxysterols Receptor LXR Beta landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Oxysterols Receptor LXR Beta include Affichem SA, Bristol-Myers Squibb Company, Kowa Company Ltd and Vitae Pharmaceuticals Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Oxysterols Receptor LXR Beta Scope and Segment
Oxysterols Receptor LXR Beta market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Oxysterols Receptor LXR Beta market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
AF-122
BMS-779788
SR-9238
VTP-38543
VTP-4
Others
Segment by Application
Clinic
Hospital
Others
By Company
Affichem SA
Bristol-Myers Squibb Company
Kowa Company Ltd
Vitae Pharmaceuticals Inc
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

レポート目次

---

1 Study Coverage
1.1 Oxysterols Receptor LXR Beta Product Introduction
1.2 Market by Type
1.2.1 Global Oxysterols Receptor LXR Beta Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 AF-122
1.2.3 BMS-779788
1.2.4 SR-9238
1.2.5 VTP-38543
1.2.6 VTP-4
1.2.7 Others
1.3 Market by Application
1.3.1 Global Oxysterols Receptor LXR Beta Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oxysterols Receptor LXR Beta Sales Estimates and Forecasts 2017-2028
2.2 Global Oxysterols Receptor LXR Beta Revenue Estimates and Forecasts 2017-2028
2.3 Global Oxysterols Receptor LXR Beta Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oxysterols Receptor LXR Beta Sales by Region
2.4.1 Global Oxysterols Receptor LXR Beta Sales by Region (2017-2022)
2.4.2 Global Sales Oxysterols Receptor LXR Beta by Region (2023-2028)
2.5 Global Oxysterols Receptor LXR Beta Revenue by Region
2.5.1 Global Oxysterols Receptor LXR Beta Revenue by Region (2017-2022)
2.5.2 Global Oxysterols Receptor LXR Beta Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oxysterols Receptor LXR Beta Sales by Manufacturers
3.1.1 Global Top Oxysterols Receptor LXR Beta Manufacturers by Sales (2017-2022)
3.1.2 Global Oxysterols Receptor LXR Beta Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oxysterols Receptor LXR Beta in 2021
3.2 Global Oxysterols Receptor LXR Beta Revenue by Manufacturers
3.2.1 Global Oxysterols Receptor LXR Beta Revenue by Manufacturers (2017-2022)
3.2.2 Global Oxysterols Receptor LXR Beta Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oxysterols Receptor LXR Beta Revenue in 2021
3.3 Global Oxysterols Receptor LXR Beta Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oxysterols Receptor LXR Beta Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oxysterols Receptor LXR Beta Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oxysterols Receptor LXR Beta Sales by Type
4.1.1 Global Oxysterols Receptor LXR Beta Historical Sales by Type (2017-2022)
4.1.2 Global Oxysterols Receptor LXR Beta Forecasted Sales by Type (2023-2028)
4.1.3 Global Oxysterols Receptor LXR Beta Sales Market Share by Type (2017-2028)
4.2 Global Oxysterols Receptor LXR Beta Revenue by Type
4.2.1 Global Oxysterols Receptor LXR Beta Historical Revenue by Type (2017-2022)
4.2.2 Global Oxysterols Receptor LXR Beta Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oxysterols Receptor LXR Beta Revenue Market Share by Type (2017-2028)
4.3 Global Oxysterols Receptor LXR Beta Price by Type
4.3.1 Global Oxysterols Receptor LXR Beta Price by Type (2017-2022)
4.3.2 Global Oxysterols Receptor LXR Beta Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oxysterols Receptor LXR Beta Sales by Application
5.1.1 Global Oxysterols Receptor LXR Beta Historical Sales by Application (2017-2022)
5.1.2 Global Oxysterols Receptor LXR Beta Forecasted Sales by Application (2023-2028)
5.1.3 Global Oxysterols Receptor LXR Beta Sales Market Share by Application (2017-2028)
5.2 Global Oxysterols Receptor LXR Beta Revenue by Application
5.2.1 Global Oxysterols Receptor LXR Beta Historical Revenue by Application (2017-2022)
5.2.2 Global Oxysterols Receptor LXR Beta Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oxysterols Receptor LXR Beta Revenue Market Share by Application (2017-2028)
5.3 Global Oxysterols Receptor LXR Beta Price by Application
5.3.1 Global Oxysterols Receptor LXR Beta Price by Application (2017-2022)
5.3.2 Global Oxysterols Receptor LXR Beta Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oxysterols Receptor LXR Beta Market Size by Type
6.1.1 North America Oxysterols Receptor LXR Beta Sales by Type (2017-2028)
6.1.2 North America Oxysterols Receptor LXR Beta Revenue by Type (2017-2028)
6.2 North America Oxysterols Receptor LXR Beta Market Size by Application
6.2.1 North America Oxysterols Receptor LXR Beta Sales by Application (2017-2028)
6.2.2 North America Oxysterols Receptor LXR Beta Revenue by Application (2017-2028)
6.3 North America Oxysterols Receptor LXR Beta Market Size by Country
6.3.1 North America Oxysterols Receptor LXR Beta Sales by Country (2017-2028)
6.3.2 North America Oxysterols Receptor LXR Beta Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Oxysterols Receptor LXR Beta Market Size by Type
7.1.1 Europe Oxysterols Receptor LXR Beta Sales by Type (2017-2028)
7.1.2 Europe Oxysterols Receptor LXR Beta Revenue by Type (2017-2028)
7.2 Europe Oxysterols Receptor LXR Beta Market Size by Application
7.2.1 Europe Oxysterols Receptor LXR Beta Sales by Application (2017-2028)
7.2.2 Europe Oxysterols Receptor LXR Beta Revenue by Application (2017-2028)
7.3 Europe Oxysterols Receptor LXR Beta Market Size by Country
7.3.1 Europe Oxysterols Receptor LXR Beta Sales by Country (2017-2028)
7.3.2 Europe Oxysterols Receptor LXR Beta Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oxysterols Receptor LXR Beta Market Size by Type
8.1.1 Asia Pacific Oxysterols Receptor LXR Beta Sales by Type (2017-2028)
8.1.2 Asia Pacific Oxysterols Receptor LXR Beta Revenue by Type (2017-2028)
8.2 Asia Pacific Oxysterols Receptor LXR Beta Market Size by Application
8.2.1 Asia Pacific Oxysterols Receptor LXR Beta Sales by Application (2017-2028)
8.2.2 Asia Pacific Oxysterols Receptor LXR Beta Revenue by Application (2017-2028)
8.3 Asia Pacific Oxysterols Receptor LXR Beta Market Size by Region
8.3.1 Asia Pacific Oxysterols Receptor LXR Beta Sales by Region (2017-2028)
8.3.2 Asia Pacific Oxysterols Receptor LXR Beta Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Oxysterols Receptor LXR Beta Market Size by Type
9.1.1 Latin America Oxysterols Receptor LXR Beta Sales by Type (2017-2028)
9.1.2 Latin America Oxysterols Receptor LXR Beta Revenue by Type (2017-2028)
9.2 Latin America Oxysterols Receptor LXR Beta Market Size by Application
9.2.1 Latin America Oxysterols Receptor LXR Beta Sales by Application (2017-2028)
9.2.2 Latin America Oxysterols Receptor LXR Beta Revenue by Application (2017-2028)
9.3 Latin America Oxysterols Receptor LXR Beta Market Size by Country
9.3.1 Latin America Oxysterols Receptor LXR Beta Sales by Country (2017-2028)
9.3.2 Latin America Oxysterols Receptor LXR Beta Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oxysterols Receptor LXR Beta Market Size by Type
10.1.1 Middle East and Africa Oxysterols Receptor LXR Beta Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oxysterols Receptor LXR Beta Revenue by Type (2017-2028)
10.2 Middle East and Africa Oxysterols Receptor LXR Beta Market Size by Application
10.2.1 Middle East and Africa Oxysterols Receptor LXR Beta Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oxysterols Receptor LXR Beta Revenue by Application (2017-2028)
10.3 Middle East and Africa Oxysterols Receptor LXR Beta Market Size by Country
10.3.1 Middle East and Africa Oxysterols Receptor LXR Beta Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oxysterols Receptor LXR Beta Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Affichem SA
11.1.1 Affichem SA Corporation Information
11.1.2 Affichem SA Overview
11.1.3 Affichem SA Oxysterols Receptor LXR Beta Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Affichem SA Oxysterols Receptor LXR Beta Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Affichem SA Recent Developments
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Corporation Information
11.2.2 Bristol-Myers Squibb Company Overview
11.2.3 Bristol-Myers Squibb Company Oxysterols Receptor LXR Beta Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bristol-Myers Squibb Company Oxysterols Receptor LXR Beta Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bristol-Myers Squibb Company Recent Developments
11.3 Kowa Company Ltd
11.3.1 Kowa Company Ltd Corporation Information
11.3.2 Kowa Company Ltd Overview
11.3.3 Kowa Company Ltd Oxysterols Receptor LXR Beta Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Kowa Company Ltd Oxysterols Receptor LXR Beta Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Kowa Company Ltd Recent Developments
11.4 Vitae Pharmaceuticals Inc
11.4.1 Vitae Pharmaceuticals Inc Corporation Information
11.4.2 Vitae Pharmaceuticals Inc Overview
11.4.3 Vitae Pharmaceuticals Inc Oxysterols Receptor LXR Beta Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Vitae Pharmaceuticals Inc Oxysterols Receptor LXR Beta Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Vitae Pharmaceuticals Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oxysterols Receptor LXR Beta Industry Chain Analysis
12.2 Oxysterols Receptor LXR Beta Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oxysterols Receptor LXR Beta Production Mode & Process
12.4 Oxysterols Receptor LXR Beta Sales and Marketing
12.4.1 Oxysterols Receptor LXR Beta Sales Channels
12.4.2 Oxysterols Receptor LXR Beta Distributors
12.5 Oxysterols Receptor LXR Beta Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oxysterols Receptor LXR Beta Industry Trends
13.2 Oxysterols Receptor LXR Beta Market Drivers
13.3 Oxysterols Receptor LXR Beta Market Challenges
13.4 Oxysterols Receptor LXR Beta Market Restraints
14 Key Findings in The Global Oxysterols Receptor LXR Beta Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Oxysterols Receptor LXR Beta Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of AF-122
Table 3. Major Manufacturers of BMS-779788
Table 4. Major Manufacturers of SR-9238
Table 5. Major Manufacturers of VTP-38543
Table 6. Major Manufacturers of VTP-4
Table 7. Major Manufacturers of Others
Table 8. Global Oxysterols Receptor LXR Beta Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Oxysterols Receptor LXR Beta Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Oxysterols Receptor LXR Beta Sales by Region (2017-2022) & (K Pcs)
Table 11. Global Oxysterols Receptor LXR Beta Sales Market Share by Region (2017-2022)
Table 12. Global Oxysterols Receptor LXR Beta Sales by Region (2023-2028) & (K Pcs)
Table 13. Global Oxysterols Receptor LXR Beta Sales Market Share by Region (2023-2028)
Table 14. Global Oxysterols Receptor LXR Beta Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global Oxysterols Receptor LXR Beta Revenue Market Share by Region (2017-2022)
Table 16. Global Oxysterols Receptor LXR Beta Revenue by Region (2023-2028) & (US$ Million)
Table 17. Global Oxysterols Receptor LXR Beta Revenue Market Share by Region (2023-2028)
Table 18. Global Oxysterols Receptor LXR Beta Sales by Manufacturers (2017-2022) & (K Pcs)
Table 19. Global Oxysterols Receptor LXR Beta Sales Share by Manufacturers (2017-2022)
Table 20. Global Oxysterols Receptor LXR Beta Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 21. Global Oxysterols Receptor LXR Beta Revenue Share by Manufacturers (2017-2022)
Table 22. Oxysterols Receptor LXR Beta Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 23. Global Oxysterols Receptor LXR Beta Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Oxysterols Receptor LXR Beta by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxysterols Receptor LXR Beta as of 2021)
Table 25. Oxysterols Receptor LXR Beta Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Oxysterols Receptor LXR Beta Product Offered
Table 27. Date of Manufacturers Enter into Oxysterols Receptor LXR Beta Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Oxysterols Receptor LXR Beta Sales by Type (2017-2022) & (K Pcs)
Table 30. Global Oxysterols Receptor LXR Beta Sales by Type (2023-2028) & (K Pcs)
Table 31. Global Oxysterols Receptor LXR Beta Sales Share by Type (2017-2022)
Table 32. Global Oxysterols Receptor LXR Beta Sales Share by Type (2023-2028)
Table 33. Global Oxysterols Receptor LXR Beta Revenue by Type (2017-2022) & (US$ Million)
Table 34. Global Oxysterols Receptor LXR Beta Revenue by Type (2023-2028) & (US$ Million)
Table 35. Global Oxysterols Receptor LXR Beta Revenue Share by Type (2017-2022)
Table 36. Global Oxysterols Receptor LXR Beta Revenue Share by Type (2023-2028)
Table 37. Oxysterols Receptor LXR Beta Price by Type (2017-2022) & (USD/Pcs)
Table 38. Global Oxysterols Receptor LXR Beta Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 39. Global Oxysterols Receptor LXR Beta Sales by Application (2017-2022) & (K Pcs)
Table 40. Global Oxysterols Receptor LXR Beta Sales by Application (2023-2028) & (K Pcs)
Table 41. Global Oxysterols Receptor LXR Beta Sales Share by Application (2017-2022)
Table 42. Global Oxysterols Receptor LXR Beta Sales Share by Application (2023-2028)
Table 43. Global Oxysterols Receptor LXR Beta Revenue by Application (2017-2022) & (US$ Million)
Table 44. Global Oxysterols Receptor LXR Beta Revenue by Application (2023-2028) & (US$ Million)
Table 45. Global Oxysterols Receptor LXR Beta Revenue Share by Application (2017-2022)
Table 46. Global Oxysterols Receptor LXR Beta Revenue Share by Application (2023-2028)
Table 47. Oxysterols Receptor LXR Beta Price by Application (2017-2022) & (USD/Pcs)
Table 48. Global Oxysterols Receptor LXR Beta Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 49. North America Oxysterols Receptor LXR Beta Sales by Type (2017-2022) & (K Pcs)
Table 50. North America Oxysterols Receptor LXR Beta Sales by Type (2023-2028) & (K Pcs)
Table 51. North America Oxysterols Receptor LXR Beta Revenue by Type (2017-2022) & (US$ Million)
Table 52. North America Oxysterols Receptor LXR Beta Revenue by Type (2023-2028) & (US$ Million)
Table 53. North America Oxysterols Receptor LXR Beta Sales by Application (2017-2022) & (K Pcs)
Table 54. North America Oxysterols Receptor LXR Beta Sales by Application (2023-2028) & (K Pcs)
Table 55. North America Oxysterols Receptor LXR Beta Revenue by Application (2017-2022) & (US$ Million)
Table 56. North America Oxysterols Receptor LXR Beta Revenue by Application (2023-2028) & (US$ Million)
Table 57. North America Oxysterols Receptor LXR Beta Sales by Country (2017-2022) & (K Pcs)
Table 58. North America Oxysterols Receptor LXR Beta Sales by Country (2023-2028) & (K Pcs)
Table 59. North America Oxysterols Receptor LXR Beta Revenue by Country (2017-2022) & (US$ Million)
Table 60. North America Oxysterols Receptor LXR Beta Revenue by Country (2023-2028) & (US$ Million)
Table 61. Europe Oxysterols Receptor LXR Beta Sales by Type (2017-2022) & (K Pcs)
Table 62. Europe Oxysterols Receptor LXR Beta Sales by Type (2023-2028) & (K Pcs)
Table 63. Europe Oxysterols Receptor LXR Beta Revenue by Type (2017-2022) & (US$ Million)
Table 64. Europe Oxysterols Receptor LXR Beta Revenue by Type (2023-2028) & (US$ Million)
Table 65. Europe Oxysterols Receptor LXR Beta Sales by Application (2017-2022) & (K Pcs)
Table 66. Europe Oxysterols Receptor LXR Beta Sales by Application (2023-2028) & (K Pcs)
Table 67. Europe Oxysterols Receptor LXR Beta Revenue by Application (2017-2022) & (US$ Million)
Table 68. Europe Oxysterols Receptor LXR Beta Revenue by Application (2023-2028) & (US$ Million)
Table 69. Europe Oxysterols Receptor LXR Beta Sales by Country (2017-2022) & (K Pcs)
Table 70. Europe Oxysterols Receptor LXR Beta Sales by Country (2023-2028) & (K Pcs)
Table 71. Europe Oxysterols Receptor LXR Beta Revenue by Country (2017-2022) & (US$ Million)
Table 72. Europe Oxysterols Receptor LXR Beta Revenue by Country (2023-2028) & (US$ Million)
Table 73. Asia Pacific Oxysterols Receptor LXR Beta Sales by Type (2017-2022) & (K Pcs)
Table 74. Asia Pacific Oxysterols Receptor LXR Beta Sales by Type (2023-2028) & (K Pcs)
Table 75. Asia Pacific Oxysterols Receptor LXR Beta Revenue by Type (2017-2022) & (US$ Million)
Table 76. Asia Pacific Oxysterols Receptor LXR Beta Revenue by Type (2023-2028) & (US$ Million)
Table 77. Asia Pacific Oxysterols Receptor LXR Beta Sales by Application (2017-2022) & (K Pcs)
Table 78. Asia Pacific Oxysterols Receptor LXR Beta Sales by Application (2023-2028) & (K Pcs)
Table 79. Asia Pacific Oxysterols Receptor LXR Beta Revenue by Application (2017-2022) & (US$ Million)
Table 80. Asia Pacific Oxysterols Receptor LXR Beta Revenue by Application (2023-2028) & (US$ Million)
Table 81. Asia Pacific Oxysterols Receptor LXR Beta Sales by Region (2017-2022) & (K Pcs)
Table 82. Asia Pacific Oxysterols Receptor LXR Beta Sales by Region (2023-2028) & (K Pcs)
Table 83. Asia Pacific Oxysterols Receptor LXR Beta Revenue by Region (2017-2022) & (US$ Million)
Table 84. Asia Pacific Oxysterols Receptor LXR Beta Revenue by Region (2023-2028) & (US$ Million)
Table 85. Latin America Oxysterols Receptor LXR Beta Sales by Type (2017-2022) & (K Pcs)
Table 86. Latin America Oxysterols Receptor LXR Beta Sales by Type (2023-2028) & (K Pcs)
Table 87. Latin America Oxysterols Receptor LXR Beta Revenue by Type (2017-2022) & (US$ Million)
Table 88. Latin America Oxysterols Receptor LXR Beta Revenue by Type (2023-2028) & (US$ Million)
Table 89. Latin America Oxysterols Receptor LXR Beta Sales by Application (2017-2022) & (K Pcs)
Table 90. Latin America Oxysterols Receptor LXR Beta Sales by Application (2023-2028) & (K Pcs)
Table 91. Latin America Oxysterols Receptor LXR Beta Revenue by Application (2017-2022) & (US$ Million)
Table 92. Latin America Oxysterols Receptor LXR Beta Revenue by Application (2023-2028) & (US$ Million)
Table 93. Latin America Oxysterols Receptor LXR Beta Sales by Country (2017-2022) & (K Pcs)
Table 94. Latin America Oxysterols Receptor LXR Beta Sales by Country (2023-2028) & (K Pcs)
Table 95. Latin America Oxysterols Receptor LXR Beta Revenue by Country (2017-2022) & (US$ Million)
Table 96. Latin America Oxysterols Receptor LXR Beta Revenue by Country (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Oxysterols Receptor LXR Beta Sales by Type (2017-2022) & (K Pcs)
Table 98. Middle East and Africa Oxysterols Receptor LXR Beta Sales by Type (2023-2028) & (K Pcs)
Table 99. Middle East and Africa Oxysterols Receptor LXR Beta Revenue by Type (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Oxysterols Receptor LXR Beta Revenue by Type (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Oxysterols Receptor LXR Beta Sales by Application (2017-2022) & (K Pcs)
Table 102. Middle East and Africa Oxysterols Receptor LXR Beta Sales by Application (2023-2028) & (K Pcs)
Table 103. Middle East and Africa Oxysterols Receptor LXR Beta Revenue by Application (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Oxysterols Receptor LXR Beta Revenue by Application (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Oxysterols Receptor LXR Beta Sales by Country (2017-2022) & (K Pcs)
Table 106. Middle East and Africa Oxysterols Receptor LXR Beta Sales by Country (2023-2028) & (K Pcs)
Table 107. Middle East and Africa Oxysterols Receptor LXR Beta Revenue by Country (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Oxysterols Receptor LXR Beta Revenue by Country (2023-2028) & (US$ Million)
Table 109. Affichem SA Corporation Information
Table 110. Affichem SA Description and Major Businesses
Table 111. Affichem SA Oxysterols Receptor LXR Beta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 112. Affichem SA Oxysterols Receptor LXR Beta Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Affichem SA Recent Developments
Table 114. Bristol-Myers Squibb Company Corporation Information
Table 115. Bristol-Myers Squibb Company Description and Major Businesses
Table 116. Bristol-Myers Squibb Company Oxysterols Receptor LXR Beta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 117. Bristol-Myers Squibb Company Oxysterols Receptor LXR Beta Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Bristol-Myers Squibb Company Recent Developments
Table 119. Kowa Company Ltd Corporation Information
Table 120. Kowa Company Ltd Description and Major Businesses
Table 121. Kowa Company Ltd Oxysterols Receptor LXR Beta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 122. Kowa Company Ltd Oxysterols Receptor LXR Beta Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Kowa Company Ltd Recent Developments
Table 124. Vitae Pharmaceuticals Inc Corporation Information
Table 125. Vitae Pharmaceuticals Inc Description and Major Businesses
Table 126. Vitae Pharmaceuticals Inc Oxysterols Receptor LXR Beta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 127. Vitae Pharmaceuticals Inc Oxysterols Receptor LXR Beta Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Vitae Pharmaceuticals Inc Recent Developments
Table 129. Key Raw Materials Lists
Table 130. Raw Materials Key Suppliers Lists
Table 131. Oxysterols Receptor LXR Beta Distributors List
Table 132. Oxysterols Receptor LXR Beta Customers List
Table 133. Oxysterols Receptor LXR Beta Market Trends
Table 134. Oxysterols Receptor LXR Beta Market Drivers
Table 135. Oxysterols Receptor LXR Beta Market Challenges
Table 136. Oxysterols Receptor LXR Beta Market Restraints
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Oxysterols Receptor LXR Beta Product Picture
Figure 3. Global Oxysterols Receptor LXR Beta Market Share by Type in 2021 & 2028
Figure 3. AF-122 Product Picture
Figure 4. BMS-779788 Product Picture
Figure 5. SR-9238 Product Picture
Figure 6. VTP-38543 Product Picture
Figure 7. VTP-4 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Oxysterols Receptor LXR Beta Market Share by Application in 2021 & 2028
Figure 10. Clinic
Figure 11. Hospital
Figure 12. Others
Figure 13. Oxysterols Receptor LXR Beta Report Years Considered
Figure 14. Global Oxysterols Receptor LXR Beta Sales 2017-2028 (K Pcs)
Figure 15. Global Oxysterols Receptor LXR Beta Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Oxysterols Receptor LXR Beta Revenue 2017-2028 (US$ Million)
Figure 17. Global Oxysterols Receptor LXR Beta Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Oxysterols Receptor LXR Beta Sales Market Share by Region (2017-2022)
Figure 19. Global Oxysterols Receptor LXR Beta Sales Market Share by Region (2023-2028)
Figure 20. North America Oxysterols Receptor LXR Beta Sales YoY (2017-2028) & (K Pcs)
Figure 21. North America Oxysterols Receptor LXR Beta Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Oxysterols Receptor LXR Beta Sales YoY (2017-2028) & (K Pcs)
Figure 23. Europe Oxysterols Receptor LXR Beta Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Oxysterols Receptor LXR Beta Sales YoY (2017-2028) & (K Pcs)
Figure 25. Asia-Pacific Oxysterols Receptor LXR Beta Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Oxysterols Receptor LXR Beta Sales YoY (2017-2028) & (K Pcs)
Figure 27. Latin America Oxysterols Receptor LXR Beta Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Oxysterols Receptor LXR Beta Sales YoY (2017-2028) & (K Pcs)
Figure 29. Middle East & Africa Oxysterols Receptor LXR Beta Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Oxysterols Receptor LXR Beta Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Oxysterols Receptor LXR Beta in the World: Market Share by Oxysterols Receptor LXR Beta Revenue in 2021
Figure 32. Global Oxysterols Receptor LXR Beta Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Oxysterols Receptor LXR Beta Sales Market Share by Type (2017-2028)
Figure 34. Global Oxysterols Receptor LXR Beta Revenue Market Share by Type (2017-2028)
Figure 35. Global Oxysterols Receptor LXR Beta Sales Market Share by Application (2017-2028)
Figure 36. Global Oxysterols Receptor LXR Beta Revenue Market Share by Application (2017-2028)
Figure 37. North America Oxysterols Receptor LXR Beta Sales Market Share by Type (2017-2028)
Figure 38. North America Oxysterols Receptor LXR Beta Revenue Market Share by Type (2017-2028)
Figure 39. North America Oxysterols Receptor LXR Beta Sales Market Share by Application (2017-2028)
Figure 40. North America Oxysterols Receptor LXR Beta Revenue Market Share by Application (2017-2028)
Figure 41. North America Oxysterols Receptor LXR Beta Sales Share by Country (2017-2028)
Figure 42. North America Oxysterols Receptor LXR Beta Revenue Share by Country (2017-2028)
Figure 43. U.S. Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Oxysterols Receptor LXR Beta Sales Market Share by Type (2017-2028)
Figure 46. Europe Oxysterols Receptor LXR Beta Revenue Market Share by Type (2017-2028)
Figure 47. Europe Oxysterols Receptor LXR Beta Sales Market Share by Application (2017-2028)
Figure 48. Europe Oxysterols Receptor LXR Beta Revenue Market Share by Application (2017-2028)
Figure 49. Europe Oxysterols Receptor LXR Beta Sales Share by Country (2017-2028)
Figure 50. Europe Oxysterols Receptor LXR Beta Revenue Share by Country (2017-2028)
Figure 51. Germany Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 52. France Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Oxysterols Receptor LXR Beta Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Oxysterols Receptor LXR Beta Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Oxysterols Receptor LXR Beta Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Oxysterols Receptor LXR Beta Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Oxysterols Receptor LXR Beta Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Oxysterols Receptor LXR Beta Revenue Share by Region (2017-2028)
Figure 62. China Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 65. India Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 67. Taiwan Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 71. Philippines Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 72. Latin America Oxysterols Receptor LXR Beta Sales Market Share by Type (2017-2028)
Figure 73. Latin America Oxysterols Receptor LXR Beta Revenue Market Share by Type (2017-2028)
Figure 74. Latin America Oxysterols Receptor LXR Beta Sales Market Share by Application (2017-2028)
Figure 75. Latin America Oxysterols Receptor LXR Beta Revenue Market Share by Application (2017-2028)
Figure 76. Latin America Oxysterols Receptor LXR Beta Sales Share by Country (2017-2028)
Figure 77. Latin America Oxysterols Receptor LXR Beta Revenue Share by Country (2017-2028)
Figure 78. Mexico Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 79. Brazil Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 80. Argentina Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Oxysterols Receptor LXR Beta Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Oxysterols Receptor LXR Beta Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Oxysterols Receptor LXR Beta Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Oxysterols Receptor LXR Beta Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Oxysterols Receptor LXR Beta Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa Oxysterols Receptor LXR Beta Revenue Share by Country (2017-2028)
Figure 87. Turkey Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 89. U.A.E Oxysterols Receptor LXR Beta Revenue (2017-2028) & (US$ Million)
Figure 90. Oxysterols Receptor LXR Beta Value Chain
Figure 91. Oxysterols Receptor LXR Beta Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed

---